1. Home
  2. NRIX vs FLYW Comparison

NRIX vs FLYW Comparison

Compare NRIX & FLYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$14.76

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Flywire Corporation Voting

FLYW

Flywire Corporation Voting

SELL

Current Price

$22.22

Market Cap

2.3B

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
NRIX
FLYW
Founded
2009
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.3B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
NRIX
FLYW
Price
$14.76
$22.22
Analyst Decision
Buy
Buy
Analyst Count
14
15
Target Price
★ $33.50
$23.39
AVG Volume (30 Days)
★ 3.4M
1.9M
Earning Date
10-12-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 450.00
EPS
★ 3.26
0.61
Revenue
$76,987,000.00
★ $623,025,000.00
Revenue This Year
$786.93
$24.36
Revenue Next Year
N/A
$14.91
P/E Ratio
★ $4.52
$36.34
Revenue Growth
★ 99.31
26.59
52 Week Low
$12.61
$10.55
52 Week High
$28.23
$22.59

Technical Indicators

Market Signals
Indicator
NRIX
FLYW
Relative Strength Index (RSI) 25.08 64.50
Support Level $14.65 $16.95
Resistance Level $17.47 N/A
Average True Range (ATR) 1.22 0.95
MACD -0.77 0.16
Stochastic Oscillator 0.23 87.32

Price Performance

Historical Comparison
NRIX
FLYW

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

About FLYW Flywire Corporation Voting

Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements, namely a payments platform, a proprietary payment network, and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.

Share on Social Networks: